Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought protection against liabilities.
from Zee News :India National https://ift.tt/3wSP9M5
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments